Search
A March 12, 2025 memo said the state had paid more than $150,000 defending itself in a lawsuit Amgen had filed over plans to set an upper payment limit on its rheumatoid arthritis treatment, Enbrel.
Read More
Senator Jim Banks asked pointed questions about how FDA will stem the tide of semaglutide and tirzepatide coming from unknown facilities.
Read More
Compounded versions of GLP-1 injectable treatments for diabetes and obesity have surged in popularity despite a lack the safety and efficacy assurances. The FDA has warned that these knockoff versions sometimes contain illicit semaglutide or tirzepatide-the active pharmaceutical ingredients (APIs) in weight loss drugs. Working with George Karavetsos, former director of FDA’s Office of Criminal Investigations and a federal prosecutor,…
Read More
“Alternative funding programs” are shifting expensive prescription coverage to illegal drug importation schemes.
Read More
Our policy focus: protect patients At the Partnership for Safe Medicines we advocate for policies that reduce patients’ exposure to counterfeit medication. We believe that safety is paramount, and that no patient should ever have to wonder if the medicine they are dispensed is real. Cheaper medicine that comes with a worry about its safety is no medicine at all.…
Read More
United States District Court Northern District of Oklahoma USA v Aaron Michael Thomas Government Sentencing Memo Filed February 2025 Read the document.
Read More
PlUnited States District Court Northern District of Oklahoma USA v Aaron Michael Thomas Plea Agreement Filed November 2024 Read the document.
Read More
United States District Court Northern District of Oklahoma USA v Aaron Michael Thomas Information Filed November 2024 Read the document.
Read More
United States District Court Northern District of Oklahoma USA v Aaron Michael Thomas and Darren Doil Means Indictment Filed January 2024 Read the document.
Read More
On March 14, the Partnership for Safe Medicines submitted comment on Customs and Border Protection’s proposed update to regulations around low-value, “de minimus” shipments.
Read More